Suita, Japan

Masaki Okamoto



Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2008-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: A Spotlight on Inventor Masaki Okamoto: Innovations in Drug Development

Introduction

Masaki Okamoto, an accomplished inventor from Suita, Japan, has made significant contributions to the field of pharmacology. With two patents to his name, Okamoto focuses on developing innovative solutions for treating various medical conditions. His work primarily addresses the challenges related to neuropsychiatric and inflammatory diseases.

Latest Patents

Okamoto's most recent patent includes a compound known as 8-(3-pentylamino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine methanesulfonate, which functions as a Corticotropin Releasing Factor (CRF) antagonist. This invention has substantial potential in treating neuropsychiatric disorders and digestive system diseases. Additionally, he holds a patent for a new crystal of triazaspiro[5.5]undecane derivatives. This crystal, which is a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride, demonstrates safety as a drug substance and has antagonistic activity against chemokine receptors. These attributes make it a valuable asset for the treatment and prevention of several inflammatory diseases, including asthma and autoimmune disorders.

Career Highlights

Masaki Okamoto is currently employed at Ono Pharmaceutical Co., Ltd., a notable name in the pharmaceutical industry. His contributions to drug development and innovation highlight his commitment to enhancing patient care through effective treatments. His patents underscore his ability to merge scientific research with practical applications in medicine.

Collaborations

Throughout his career, Okamoto has collaborated with talented coworkers, including Tomoyuki Hasegawa and Toshiaki Matsui. Such partnerships enhance the research capabilities within the organization and contribute to the development of groundbreaking therapeutics.

Conclusion

Masaki Okamoto stands out as a prolific inventor whose patents are paving the way for advancements in the treatment of serious medical conditions. His dedication to innovation and collaboration at Ono Pharmaceutical Co., Ltd. ensures that he will continue to contribute significantly to the fields of pharmacology and drug development in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…